Effect of Bacopa Monnieri on Working Memory and Cognitive Processing in Student
NCT ID: NCT02931747
Last Updated: 2017-08-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
75 participants
INTERVENTIONAL
2016-07-31
2017-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Influence of Food for Special Dietary Use - Spread Enriched With 5-hydroxytryptophan, Theanine and Gamma-aminobutyric Acid on Psychophysiological Functions of Subjects Without Meaningful Organic and Cognitive Pathology
NCT05543811
The Effects of Modafinil on Waking Function and on Sleep in Individuals With Primary Insomnia
NCT00124384
Melatonin Intervention For Neurocognitive Deficits in the St. Jude Lifetime Cohort
NCT01700959
Study of the Efficacy of Dietary Supplementation in Targeting Sleep Quality (NutriSom-01B)
NCT07200167
Study to Assess Impact of Dietary Supplement on Sleep Health
NCT05971771
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
Subjects are received the pill of placebo which has same color, shape and smell like the Bacopa Monnieri once daily for 16 weeks.
Placebo
Subjects are received Placebo once daily for 16 weeks.
Bacopa Monnieri 300 mg/day
Subjects are received the pill of Bacopa Monnieri at the dose of 300 mg/day once daily for 16 weeks
Bacopa Monnieri 300 mg/day
Subjects are received Bacopa Monnieri at the dose of 300 mg/day once daily for 16 weeks.
Bacopa Monnieri 600 mg/day
Subjects are received the pill of Bacopa Monnieri at the dose of 600 mg/day once daily for 16 weeks
Bacopa Monnieri 600 mg/day
Subjects are received Bacopa Monnieri at the dose of 600 mg/day once daily for 16 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Placebo
Subjects are received Placebo once daily for 16 weeks.
Bacopa Monnieri 300 mg/day
Subjects are received Bacopa Monnieri at the dose of 300 mg/day once daily for 16 weeks.
Bacopa Monnieri 600 mg/day
Subjects are received Bacopa Monnieri at the dose of 600 mg/day once daily for 16 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body mass index is between 18.5-24.9
Exclusion Criteria
* Subjects who take any medicine or nutraceuticals or hormone that effect on central nervous system are excluded.
* Alcohol addict or smoking addiction (more than 10 pieces/day)
* Athlete or subjects who have a regular exercise more than 3 times/week
* Subjects who don't follow the instruction during the trial
* Subjects who are participating the other project.
15 Years
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Government Pharmaceutical Organization
UNKNOWN
Khon Kaen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jintanaporn Wattanathorn
Associated Professor Doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jitanaporn Wattanathorn
Khon Kaen, , Thailand
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HE581418
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.